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1. Introduction 
1.1 Progesterone synthesis 
Progesterone was independently discovered by different research groups (Butenandt & 
Westphal 1934, Allen 1935). Allen and collaborators discovered progesterone in 1933, and 
were the first to determine the molecular weight and partial molecular structure. The name 
progesterone derives from progestational steroidal ketone (Allen 1935). 
 
 
Fig. 1. Steroid hormone synthesis. The precursor cholesterol from the maternal circulation is 
converted to 21 carbon (C21) progestagens. Progestagens can be converted to C21 
glucocorticoids, or to C19 androgens. Androgens serve as precursors for C18 estrogens. 
Source: Wikipedia. 
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Progesterone belongs to the C21 group of progestagens and is the evolutionary most 
conserved of the reproductive steroid hormones. The synthesis of progesterone from its 
precursor cholesterol in the maternal circulation requires only two enzymatic steps to 
form pregnenolone, which is readily transformed to progesterone. The main source of 
progesterone in humans is the corpus luteum in the ovary. After conception, the corpus 
luteum is supported by the secretion of human chorionic gonadotropin (hCG) from the 
conceptus, and produces progesterone until approximately the 10th gestational week. 
After a transition period by 7-10 gestational weeks the placenta becomes the major 
progesterone source, using circulating cholesterol as a substrate, after which maternal 
serum levels of progesterone increase markedly. Progesterone in serum is to 95-99% 
bound to corticosteroid binding globulin (CBG) almost as tightly as glucocorticoids 
(Speroff et al 1994). 
Progesterone accompanies and modulates estrogen action. Whereas progesterone is 
synthesized in the placenta, neither the placenta nor the fetal adrenal glands are capable of 
producing sufficient quantities of precursors for estrogen synthesis. This observation led to 
the coining of the unique endocrine system “the maternal-fetal-placental unit” (Diczfalucy 
1969). In early pregnancy, the maternal circulation provides androgen precursors for 
estrogen synthesis. By 20 gestational weeks the majority of androgen precursors, 
predominantly dehydroepiandrosterone sulphate (DHEAS), are derived from the fetal 
adrenals. The fetal compartment is extremely efficient in sulphate conjugation of steroid 
hormones, protecting the fetus from high steroid concentrations. About 30% of circulating 
estrogens  are loosely bound to albumin, whereas the major amount is tightly bound to sex 
hormone binding globulin (SHBG) (Speroff et al 1994). 
2. Mechanisms of action 
2.1 Genomic effects 
The nuclear progesterone receptor (nPR) belongs to the steroid supergroup of transcription 
factor proteins (O´Malley et al 1990). All steroid receptor proteins  are composed of a variable 
N-terminal domain which activates gene transcription and protein-protein interactions, 
determining the biological response of the steroid, an evolutionary highly conserved  DNA-
binding domain, a flexible hinge region and a C-terminal ligand-binding domain. The 
classic genomic mechanism of steroid action involving mRNA and protein synthesis is slow, 
occurring over hours to days. 
The nPR binds to progesterone, and with a much less affinity to cortisol (Sanborn et al 1976). 
The biological response to progesterone is dependent on the levels and ratios of the nPR 
isoforms. The nPR isoforms A (nPR-A) (94 kDa) and nPR-B (116 kDa) are transcribed from 
the same gene, being activated by different promoters. The nPR-B isoform contains an 
additional 164 amino acids at the N-terminal and activates progesterone responsive genes. 
The nPR-A isoform is a weaker  activator of transcription than nPR-B and can act as an 
inhibitor of  nPR-B and other steroid receptors such as the nuclear estrogen (nER) and 
nuclear glucocorticoid (nGR) receptors (Vegeto et al 1993, Pieber et al 2001). A third nPR-C 
isoform has been identified in human myometrium (Condon et al 2006). nPR-C lacks a large 
segment of the N-terminal and a major part of the DNA-binding domain, and therefore 
cannot bind to DNA.   
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Fig. 2. The steroid hormone receptor family. A. Phylogenetic tree of the steroid hormone 
receptors  showing the evolutionary interrelationships between the receptors . B. Sequence 
homologies of intracellular steroid hormone receptor proteins showing the N-terminal domain 
(A/B), the DNA-binding domain (DBD, C), the hinge region (D) and the C-terminal ligand 
binding domain (LBD, E). The human estrogen receptor subtypes (ERand ER), 
glucocorticoid receptor (GR), progesterone receptor isoforms (PRA and PRB), androgen 
receptor (AR), and mineralocorticoid receptor (MR) are described. The estrogen receptor is 
unique in that it contains an additional C-terminal F domain. Numbers represent the amino 
acid sequency of the receptors. In Griekspoor A, et al. Nuclear Receptor Signaling (2007) 5, e003. 
2.2 Non-genomic effects 
Steroid hormones have been shown to initiate rapid actions, which cannot be explained by 
the slow genomic mechanisms. Such rapid actions occur within seconds through the 
activation of intracellular signaling pathways resulting in alterations in ion fluxes and 
intracellular free calcium concentrations (Blackmore et al 1991), and within minutes through 
the activation of other second messengers, such as cyclic nucleotides and extracellular-
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regulated kinase (ERK) 1 and 2 (Filardo et al 2000). Recently, three new putative membrane 
progesterone receptors (mPRs), mPR┙, mPR┚, and mPR┛ were identified in humans (Zhu et 
al 2003).  
 
 
Fig. 3. G (guanine nucleotide-binding) protein-coupled transmembrane (TM) receptors 
communicate signals from hormones and other signaling factors to intracellular messengers. 
They consist of the Gand the tightly associated G subunits. Here guanosine-
triphosphate (GTP)  is hydrolyzed by Gsubunit to guanosine-diphosphate (GDP). Source: 
CellMosaic, Worcester, MA, US. 
 
 
Fig. 4. Nuclear and transmembrane-bound progesterone receptors mediating genomic and 
non-genomic effects. Progesterone (P) activates A. Genomic pathways through nuclear 
receptor proteins (PR-A, PR-B) resulting in gene activation (slow process) and/or B. Non-
genomic pathways via membrane-bound receptors, which activate secondary messengers 
(fast process). 
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3. Systemic effects  
Serum levels of progesterone increase progressively during human pregnancy and remain 
high until delivery of the placenta (Csapo et al 1973, Speroff et al 1994, Stjernholm et al 1997). In 
other species, such as rodents and rabbits, which depend on an active corpus luteum for 
progesterone synthesis throughout pregnancy, labor is initiated by prostaglandin 
F2PGF2 from the endometrium, activating prostaglandin F (FP)-receptors in the corpus 
luteum leading to luteolysis (Sugimoto et al 1997). These observations led to the concept of a 
“functional progesterone withdrawal” at parturition in humans (Hertelendy & Zakar 2004).  
3.1 The placenta 
Placental concentrations of progesterone reach 1-10 M (Stites & Siiteri 1983, Miyaura & Iwata 
2002), whereas serum concentrations  reach 100-500 nM until term pregnancy before labor 
(Stjernholm et al 1997; Miyaura & Iwata 2002). 
3.2 The vascular system 
Increased levels of prostacyclin (PGI2) are considered to be a factor behind the physiological 
angiotensin resistance observed  in normal pregnancy (Friedman 1988). A progesterone 
induced mechanism behind this refractoriness to angiotensin  has been suggested (Everett et 
al 1978, Rupnow et al 2002). Nitric oxide (NO) and protein kinase C (PKC) pathways are 
involved in the regulation of vascular tone during pregnancy (Kublickiene et al 1997, Chang et 
al 2008). 
3.3 The respiratory system 
The pulmonary function is not impaired by pregnancy, but the tidal volume, minute 
ventilator volume and minute oxygen uptake increase with advancing gestation. This 
pregnancy-induced respiratory alkalosis is partially compensated for by increased renal 
excretion of bicarbonate. As a consequence, maternal arterial pH is increased to 7.46. The 
increased respiratory effort and decrease in PCO2 has been related to progesterone and to a 
lesser degree  to estrogen (Wolfe et al 1998, Jensen et al 2005). 
4. The uterus 
4.1 The decidua at implantation 
Successful maintenance of pregnancy depends on maternal tolerance of the fetal semi-
allograft (Szekeres-Bartho 2002). Progesterone, cortisol and prolactin have strong 
immunomodulatory effects leading to  immunotolerance during pregnancy (Stites & Siiteri 
1983, Speroff et al 1994). The human decidua is adjacent to the myometrium, the fetal 
trophoblasts of the placenta and to the fetal membranes. Natural killer (NK) cells is the 
predominant immune cell in the decidua before implantation and in early pregnancy, 
constituting 70% of decidual immune cells, followed by macrophages constituting about 
10%of total decidual cells, dendritic cells (DC) and T lymphocytes. The local endocrine 
environment regulates the recruitment of monocytes into the uterus, and the subsequent 
differentiation of monocytes  into macrophages with specific phenotypes promoting 
immunotolerance or inflammation (Stout et al  2004). Colony-stimulating factor (CSF)-1, 
macrophage migration inhibitory factor (MIF), monocyte chemoattractant protein (MCP)-1 
and regulated on activation, normal T cell expressed, and secreted (RANTES) have been 
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suggested as factors involved in the recruitment and modulation of decidual macrophages, 
and are synthesized by decidual stromal cells, NK-cells and trophoblasts at the maternal-
fetal interface (Wood et al, 1997; Lockwood et al 2006). Resident decidual macrophages appear 
to express immunosuppressive actions that favor the maintenance of pregnancy. In contrast, 
monocytes/macrophages migrating into the lower uterine segment prior to parturition are 
involved in the inflammatory process associated with cervical ripening and labor initiation 
(Nagamatsu et al 2010). A switch in decidual type 1 (Th1) to type 2 (Th2) T cell dominance in 
the fetal-placental interface has been suggested to play a crucial role in the establishment of  
pregnancy (Wegmann et al 1993). Human Th1 T-cells are the main effectors of host defence 
and Th1-type cytokines produce proinflammtory responses. The Th-1 response involves 
interferon (IFN)-, interleukin-2 (IL-2), tumor necrosis factor (TNF)-, and the generation of 
cell-mediated immunity. On the contrary, human Th2 T cells inhibit macrophage functions. 
A Th2 response involves IL-4, IL-5, anti-inflammatory IL-10, IL-10, IL-13, and the 
stimulation of humoral immunity (Abbas et al 1996, Weiner et al 2001).  
 
 
Fig. 5. Endocrine and immune cross-talk in the fetal-maternal interface at implantation. CL= 
corpus luteum, HCG= human chorionic gonadotropin. In Fujiwara H. Molecular Human 
Reproduction (2009) 15, 335–343. 
Progesterone at concentrations higher than  in serum but comparable to those in the 
maternal-fetal interface induces differentiation of T cells along the Th2 pathway (Stites & 
Siiteri 1983; Piccinni et al 1995, Miyaura & Iwata 2002). Glucocorticoids and 1,25-dihydroxy 
Vitamin D increase IL-4 (Rook et al 1994), whereas dihydrotestosterone decreases IL-4 and 
IL-5 production (Vacca et al  1990).  
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The progesterone induced protective immune environment in the decidua during early 
pregnancy includes production of  the immunomodulatory progesterone-induced blocking 
factor (PIBF) protein by decidual cells (Szekeres-Bartho et al 1985, Piccinni et al 1995). The 
presence of  nPRs in immune cells has been debated. nPRs in the thymus are necessary for 
progesterone induced involution of the thymus during pregnancy (Tibbetts et al 1999). Most 
studies have showed an absence of nPRs in lymphocytes from nonpregnant women 
(Szekeres-Bartho et al 1990, Mansour et al 1994, Bamberger et al 1999). Recently, transcripts for 
mPRand mPRbut not mPR, were detected in human peripheral blood leukocytes and T 
lymphocytes. Progesterone activated an inhibitory G-protein (Gi), suggesting that mPRs are 
coupled to Gi. These results suggest a potential novel mechanism for progesterone’s 
immunoregulatory function through activation of mPRs (Dosiou et al 2008). 
The establishment of human pregnancy is associated with an adequate synthesis of 
leukemia inhibitory factor (LIF), and macrophage colony-stimulating factor (M-CSF) 
producing T-cells. Progesterone at concentrations comparable to those in the maternal-fetal 
interface  induces LIF and M-CSF (Piccinni 2010). 
4.2 The myometrium 
The corpus uteri is a muscular organ with about 70% smooth muscle cells surrounded by 
extracellular matrix (Danforth 1954). Progesterone is holding the uterine myometrium in a 
quiescent  state,  “a progesterone block”, during pregnancy  by suppressing the propagation 
of electrical activity between the excitable myocyte membranes (Csapo 1956, Csapo et al 1973).  
The genomic and nongenomic pathways co-operate to maintain myometrial relaxation. At 
parturition, a functional progesterone withdrawal occurs by increased expression of the 
nPR-A and/or nPR-C to nPR-B ratios and changes in nPR co-regulator levels which result in 
repression of the nPR-B transcriptional activity. The diminished progesterone influence 
leads to an estrogen dominance (Mesiano et al 2002). Prostaglandins have been shown to 
induce an increased nPR-A/nPR-B ratio through the protein kinase C (PKC) pathway in  
human myometrial cells (Madsen et al 2004). Proinflammatory IL-1 up-regulates nPR-C in 
human myometrial cells, leading to diminished activation of nPR-B (Condon et al 2006). The 
increased expression of specific membrane-associated PRs (mPRs) at parturition augments 
contractility by decreasing intracellular cyclic adenosine monophosphate (cAMP) and 
altering intracellular Ca2+ levels. (Pieber et al 2001, Mesiano et al 2002, Madsen et al  2004, 
Mesiano 2007).   
5. The cervix uteri 
The cervix uteri is up to 85% composed by connective tissue, which is dominated by collagen 
fibers. Fibroblasts, smooth muscle cells, T and B lymphocytes, leukocytes and Langerhans cells 
are scattered within the tissue (Danforth & Evanston 1954, Schwalm & Dubrauszky 1966, 
White et al 1997). Cervical remodeling  is a prerequisite for cervical effacement and dilatation 
prior to labor and is characterized by increased levels of vascular adhesion molecules (VCAM), 
diapedesis and activation of neutrophils, monocytes/macrophages, T lymphocytes, mast cells, 
eosinophils, the release of proinflammatory cytokines such as IL-1and the strong 
chemotactor IL-8, and increased tissue concentrations of metalloproteinase enzymes (MMPs) 
(Junquiera et al 1980, Liggins 1981, Uldbjerg et al 1983, Bokström et al 1997, Sennström et al 2000, 
Stygar et al 2002, Winkler et al 2003). At parturition, a functional progesterone withdrawal 
occurs in the cervix uteri with decreased total nPR and an increased nPR-A/nPR-B ratio 
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(Stjernholm et al 1997, Vladic Stjernholm et al 2004). These endocrine and inflammatory events 
are followed by an up to 30-50% decreased collagen concentration, and an altered 
proteoglycan composition with a decreased density of the small proteoglycan decorin and an 
increased density of the large proteoglycan Versican. These events result in dispersed collagen 
fibrils clinically recognized as cervical effacement and dilatation  (Uldbjerg et al 1983, Ekman et 
al 1986, Norman et al 1993, Stjernholm et al 1997). Evidence suggest that progesterone effects on 
the cervix uteri are even more pronounced than its effects on the myometrium (Romero 2007). 
 
 
Fig. 6. Cervical effacement and dilatation before labor onset.  
6. Parturition 
6.1 Animal studies 
Classical experiments in sheep demonstrated that parturition in this species is initiated by 
activation of the fetal hypothalamic pituitary adrenal (HPA) axis leading to increased fetal 
cortisol secretion and induction of placental P450 enzymes (17-hydroxylase and 17-20-lyase 
activities), which favor the conversion of C21 to C18 steroids (Liggins 1974, Anderson et al 1975).  
6.2 Human parturition 
Progesterone is the main progestational hormone in humans, whereas the HPA axis has a 
modulatory function (Hertelendy & Zakar 2004). Prostaglandins (PGs) from the E and F series 
are considered to be the main promoters of cervical ripening and myometrial contractility, and 
the influence of PG-E2 in promotion of cervical maturation and uterine vasodilatation has been 
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suggested as the primary functions of PGs in human parturition (Hertelendy & Zakar 2004). 
Human decidual macrophages synthetize PGs (Norwitz 1991). Mechanical stretch of the lower 
uterine segment, proinflammatory cytokines such as IL-1 and the peptide hormone oxytocin 
induce PG synthesis (Molnar et al 1999, Allport et al 2001, Leguizamon et al 2001).  
Successful treatment with PG-E2 for cervical priming before labor induction, allowing for 
resulting in cervical effacement and dilatation allowing for parturition was associated with 
diminished cervical progesterone and androgen receptor concentrations (Vladic Stjernholm, 
2009). 
7. The puerperium 
After delivery of the placenta, serum concentrations of estrogen and progesterone decrease 
within hours, and the puerperuim (puer: infant, pario: give birth) is a hypoestrogenic and 
hypoprogestagenic state. The high progesterone level during pregnancy inhibits lactation. 
The fall in progesterone levels after delivery is one factor that stimulates milk production  
(Tucker 1979). 
8. Progestin and progesterone treatment  
Natural progesterone and synthetic progestins do both exert a progestogenic effect, defined 
as the decidualizing effect on estrogen-primed rabbit endometium (Elton  1966, Schindler et al 
2003). 
8.1 Progestins and progesterone for preventing miscarriage  
In clinical practice, progestin treatment was practised since the 1950s as luteal phase support to 
prevent miscarriage during the first trimester of pregnancy. The amount of data from well-
controlled clinical trials is limited. Further studies are required to establish the optimal 
treatment situation as well as type and dose of progestin (LeVine et al  1964, Daya & Gunby 2004).  
8.2 Progestins and progesterone for preventing premature birth  
Since the 1960s studies on treatment with synthetic progestins for preventing premature 
childbirth have reported beneficial effects. Human pregnancy lasts 40 gestational weeks and 
birth between 22 and 37 weeks is defined as premature (WHO 1977). The highly active 
progesterone ester 17-hydroxyprogestrone caproate has a long duration allowing for 
 
 
Fig. 7. The synthetic progestin 17-hydroxyprogesterone caproate. 
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intramuscular administration 1-3 times weekly. It has been administered to risk groups with 
previous recurrent abortions or previous premature births and to patients with premature 
contractions and short cervices (Johnsson et al 1976, Meis et al 2003, Dodd et al 2006). Natural 
progesterone has been administered as of vaginal gel to such risk groups and in situations 
with premature contractions and short cervices (daFonseca et al 2003, deFranco et al 2007, 
O´Brien et al 2007). Reduced incidence of premature birth before 32, 34 and 37 gestational 
weeks and improved neonatal outcome were reported (Brent 2005). Further studies are 
required to establish the optimal dose and type of agent as well as long term effects on the 
newborn.  
9. Summary 
Progesterone is the evolutionary most conserved of the reproductive steroid hormones. It is 
the main progestational hormone in humans, and its strong immunomodulatory effects are 
important for the physiological immunotolerance at implantation. After a transition period 
by 7-10 gestational weeks the placenta becomes the major progesterone source. Placental 
concentrations of progesterone reach 1-10 M and serum concentrations 100-500 nM until 
term pregnancy. Progesterone exerts its effects through genomic nuclear receptor mediated 
and non-genomic transmembrane receptor mediated processes, keeping the myometrium in 
a quiescent state and stabilizing the cervix uteri during pregnancy. A functional 
progesterone withdrawal occurs at human parturition with a diminished total receptor 
density and altered isoform ratios. In clinical practice, progestin treatment has been given as 
luteal phase support to prevent miscarriage during the first trimester of pregnancy. 
Treatment with synthetic progestins and natural progesterone has been shown to reduce the 
incidence  of  premature birth. Further studies are required to establish the optimal dose and 
type of agent as well as long term effects on the newborn.  
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